Budget 2017: Reaction from the UK’s pharmaceutical industry
The Chief Executive of the Association of the British Pharmaceutical Industry (ABPI), Mike Thompson responds to the UK’s Budget announcement...
List view / Grid view
News
EC extends license for Zytiga to treat early stage prostate cancer
The EC has granted approval to broaden the existing marketing authorisation for Zytiga to include early stage metastatic prostate cancer...
Lansoprazole a gastric acid suppressant may target TB
A cheap and widely used drug, used to treat conditions such as heartburn, gastritis and ulcers, could work against the bacteria that cause TB...
EMA grants marketing authorisation for Zubsolv for opioid dependence
The EMA has granted a Marketing Authorization for Zubsolv, a novel rapidly-disintegrating treatment option for opioid dependence...
FGF inhibitors may provide a new way to treat high blood pressure
Drugs designed to halt cancer growth may offer a new way to control high blood pressure...
Boehringer Ingelheim makes its best molecules available to the scientific community
Boehringer Ingelheim has announced the launch of a new platform offering free and open access to selected pre-clinical molecules for a non-clinical investigation to scientists worldwide...
EMA to relocate to Amsterdam, the Netherlands
The EMA will relocate to Amsterdam in the Netherlands. The Agency now has just over 16 months to prepare for the move and take up its operations in Amsterdam on 30 March 2019 at the latest...
FDA approves Hemlibra to prevent bleeding in patients with haemophilia A
Hemlibra has been approved to prevent the frequency of bleeding episodes in patients who have developed FVIII inhibitors...
Cell-weighing method may predict how drugs will affect cancer cells
Cell-weighing technique may predict which therapies a patient is most sensitive or resistant to...
Anti-malaria drug shows promise as Zika virus treatment
Chloroquine found to reduced the amount of Zika virus in maternal blood and neural progenitor cells in the foetal brain
Could Milan be the new home for the EMA?
Wayne Pines, President of Healthcare at APCO Worldwide in Washington DC and a former Associate Commissioner of the FDA believes Milan is a logical choice for the relocation of the European Medicines Agency...
Tapeworm drug fights prostate cancer
A Norwegian study shows that NTZ contains a substance that can kill prostate and colon cancer...
FDA approves Fasenra for severe eosinophilic asthma
The FDA has approved Fasenra for the add-on maintenance treatment of patients with severe asthma aged 12 years and older...
NICE recommends Kisqali as a cost-effective treatment for advanced breast cancer
NICE recommends Kisqali as a cost-effective treatment option for postmenopausal women within England and Wales with advanced breast cancer...
British Biosimilars Association appoints new chair
The BBA, the representative group of biosimilar manufacturers in the UK, has announced that Kavya Gopal will become its new chair with immediate effect...
